ZA767496B - Etherified clavulanic acid derivatives - Google Patents

Etherified clavulanic acid derivatives

Info

Publication number
ZA767496B
ZA767496B ZA00767496A ZA767496A ZA767496B ZA 767496 B ZA767496 B ZA 767496B ZA 00767496 A ZA00767496 A ZA 00767496A ZA 767496 A ZA767496 A ZA 767496A ZA 767496 B ZA767496 B ZA 767496B
Authority
ZA
South Africa
Prior art keywords
etherified
acid derivatives
clavulanic acid
clavulanic
derivatives
Prior art date
Application number
ZA00767496A
Other languages
English (en)
Inventor
P Cherry
P Ward
G Gregory
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of ZA767496B publication Critical patent/ZA767496B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
ZA00767496A 1975-12-17 1976-12-17 Etherified clavulanic acid derivatives ZA767496B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51688/75A GB1573503A (en) 1975-12-17 1975-12-17 Clavulanic acid derivatives

Publications (1)

Publication Number Publication Date
ZA767496B true ZA767496B (en) 1978-02-22

Family

ID=10461003

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00767496A ZA767496B (en) 1975-12-17 1976-12-17 Etherified clavulanic acid derivatives

Country Status (10)

Country Link
JP (1) JPS5293792A (da)
AU (1) AU2064576A (da)
BE (1) BE849475A (da)
DE (1) DE2657048A1 (da)
DK (1) DK565676A (da)
FR (1) FR2335222A1 (da)
GB (1) GB1573503A (da)
NL (1) NL7613965A (da)
SE (1) SE7614181L (da)
ZA (1) ZA767496B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (fr) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Derives de la clavuline et leur procede de preparation
GB1587612A (en) * 1976-10-30 1981-04-08 Beecham Group Ltd Isoclavulanic acid derivatives
GB1595176A (en) * 1976-12-03 1981-08-12 Beecham Group Ltd Clavulanic acid ethers
IL53465A (en) * 1976-12-11 1980-11-30 Beecham Group Ltd Process for the preparation of clavulanic acid ethers and some novel compounds of this type
DK139377A (da) * 1977-03-10 1978-09-11 Beecham Group Ltd Fremgangsmaade til fremstilling af ethere
DE3062347D1 (en) * 1979-08-11 1983-04-21 Beecham Group Plc Process for the preparation of derivatives of clavulanic acid
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
FR2335222A1 (fr) 1977-07-15
SE7614181L (sv) 1977-06-18
JPS5293792A (en) 1977-08-06
GB1573503A (en) 1980-08-28
DE2657048A1 (de) 1977-06-23
AU2064576A (en) 1978-06-22
DK565676A (da) 1977-06-18
FR2335222B1 (da) 1982-06-11
BE849475A (fr) 1977-06-16
NL7613965A (nl) 1977-06-21

Similar Documents

Publication Publication Date Title
HK23979A (en) Piperidyl-triazine derivatives
GB1550160A (en) 4-hydroxypyrrolidin-2-one derivatives
GB1520812A (en) Benzhydrylsulphinyl derivatives
IL48209A0 (en) Amidinourea derivatives
IL49706A (en) Anhydro-vinca derivatives
AU506250B2 (en) Clavulanic acid derivatives
AU1597876A (en) Ortho-aminobutyrophenone derivatives
HK48983A (en) Clavulanic acid derivatives
ZA767496B (en) Etherified clavulanic acid derivatives
GB1540845A (en) 6-oxo-pyrimidine derivatives
AU1074176A (en) Oxadiazolinone derivatives
AU1855676A (en) Clavulanic acid derivatives
GB1547169A (en) Clavulanic acid derivatives
IE44308L (en) Androsten-17-one derivatives
HK25682A (en) Cis-bicyclooctyl-alkyl-amine derivatives
GB1486104A (en) Phthalimidopiperidine derivatives
GB1554720A (en) Pyridthione derivatives
AU1661376A (en) Morphanthridine derivatives
GB1545577A (en) N-alkyl-3-phenylisoxazole-4-carboxamide derivatives
IL49102A0 (en) Triazolobenzocycloalkylthiadiazine derivatives
AU497577B2 (en) Clavulanic acid derivatives
GB1542405A (en) Clavulanic acid derivatives
GB1520011A (en) Benodioxole derivatives
GB1520682A (en) Monochloro-striazine derivatives
IL48972A0 (en) Triazolocycloalkylhydrothiadiazine derivatives